Advertisement

Supply Chain


The 2.3 percent excise tax imposed on medical devices in 2013 as part of the Affordable Care Act significantly reduced R&D investment, sales revenue, gross margins and earnings, according to a study published in Research Policy. 

ASC supply chain leaders should look at the top 25 percent of costliest inventory items and evaluate whether purchasing in a low measure would deliver better long-term results, according to Quorum Purchasing Advantage Vice President Tony Bramer.

Advertisement
Advertisement
Advertisement